Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Preferred Stock Liabilities (2022 - 2024)

SBC Medical Group Holdings filings provide 3 years of Preferred Stock Liabilities readings, the most recent being $2.2 million for Q2 2024.

  • On a quarterly basis, Preferred Stock Liabilities fell 89.23% to $2.2 million in Q2 2024 year-over-year; TTM through Jun 2024 was $2.2 million, a 89.23% decrease, with the full-year FY2023 number at $20.6 million, changed 0.0% from a year prior.
  • Preferred Stock Liabilities hit $2.2 million in Q2 2024 for SBC Medical Group Holdings, down from $2.3 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $119.7 million in Q1 2023 to a low of $2.2 million in Q2 2024.
  • Median Preferred Stock Liabilities over the past 3 years was $20.5 million (2023), compared with a mean of $29.5 million.
  • Biggest five-year swings in Preferred Stock Liabilities: changed 0.0% in 2023 and later plummeted 98.07% in 2024.
  • SBC Medical Group Holdings' Preferred Stock Liabilities stood at $20.6 million in 2022, then changed by 0.0% to $20.6 million in 2023, then plummeted by 89.39% to $2.2 million in 2024.
  • The last three reported values for Preferred Stock Liabilities were $2.2 million (Q2 2024), $2.3 million (Q1 2024), and $20.6 million (Q4 2023) per Business Quant data.